Company intelligence / Profile preview

Tozaro

Bedfordshire, United Kingdomtozaro.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Tozaro has developed rationally designed smart polymer affinity reagents that have demonstrated positive results in analytics and capture chromatography for lentiviral vectors. These reagents are enabling more efficient, scalable, and cost-effective downstream processing in the manufacture of viral vectors used in cell and gene therapy. The company is expanding its portfolio to cover additional vector types.

Therapeutic areas: Other
Modalities: Reagent (Smart polymer affinity reagent)Polymer-based technology (enabling analytics and purification of viral vectors)
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Tozaro.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tozaro.

Explore the full profile